Anthony D Bruno

CIK 1374180 · Exec. V.P., Corp. Development · last filed 2024-12-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

22

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VYNE Director $0.65 $0 5 2024-12-13
VYNE Therapeutics Inc. (MNLO) Delisted Director 135,056 $0 4 2020-08-05
Foamix Pharmaceuticals Ltd. (FOMX) Delisted Director 75,007 $0 2 2020-03-03
Warner Chilcott plc (WCRX) Delisted Exec. V.P., Corp. Development 970,774 $0 1 2009-01-22

Recent Filings · Page 2 of 3

22 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-03-03 Foamix Pharmaceuticals Ltd. (FOMX) Delisted Grant (A) +5,312 $0 EDGAR
2019-05-20 Foamix Pharmaceuticals Ltd. (FOMX) Delisted Grant (A) +28,195 $0 EDGAR
2012-01-03 Disp (D) −61,512 $0
2011-03-31 Sell (S) −16,848 -$391.7K
2011-03-17 Sell (S) −400,000 -$9.30M
2011-02-18 Grant (A) +40,370 $0
2011-02-01 Sell (S) −2,152 -$50.2K
2011-01-24 Sell (S) −4,097 -$96.8K
2010-02-02 Grant (A) +22,970 $0
2010-01-22 Mixed −146,519 -$116.1K
Showing 1120 of 22
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.